What is The Pennant Group, Inc.'s (PNTG) StockRank?

MoatMap's StockRank for The Pennant Group, Inc. (PNTG) is 66/100, with a Buy signal. This is a composite score combining Quality (51), Value (28), and Momentum (81) factor ranks across MoatMap's 20,000+ stock universe.

Does The Pennant Group, Inc. have an economic moat?

The Pennant Group, Inc. (PNTG) has a Quality factor score of 51/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the financial characteristics of a moated business.

Is The Pennant Group, Inc. a buy, hold, or sell?

MoatMap's current signal for The Pennant Group, Inc. (PNTG) is Buy, based on a StockRank of 66/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.

What sector is The Pennant Group, Inc. in?

The Pennant Group, Inc. (PNTG) operates in the Healthcare sector, specifically the Medical Care Facilities industry (United States).

Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

PNTG

BUY

The Pennant Group, Inc. · Healthcare · United States · $1.4B · Avg Vol: $13M/d

StockRank

Get insider-trade alerts

P/E (TTM)

49.0x

ROE

10.0%

D/E

1.2x

Dividend %

—

COMPANY DESCRIPTION

The Pennant Group, Inc. is a healthcare services company operating home health, hospice, and senior living facilities across multiple states. The company's competitive edge is its localized, de-centralized operating model that empowers local leaders to tailor services to their communities, fostering strong relationships and high-quality care. It is a growing player in the post-acute and senior care markets.

FINANCIAL SUMMARY (USD)

Year	2022	2023	2024	2025	CAGR	TTM	2026E	2027E	Fwd CAGR
Revenue	473.2M	544.9M	695.2M	947.7M	26.0%	1.0B	1.2B	1.3B	15.1%
EPS	0.23	0.45	0.72	0.86	55.2%	0.84	0.99	1.17	16.4%
Shares	29.7M	29.9M	34.4M	34.6M	+16.6%	34.8M	—	—	—
Debt	326.6M	329.6M	273.1M	453.2M	11.5%	454.1M	—	—	—
Equity	121.0M	140.3M	293.3M	332.6M	40.1%	—	—	—	—
Op CF	9.0M	33.1M	39.3M	48.3M	74.8%	66.1M	—	—	—
Inv CF	-24.2M	-30.2M	-70.7M	-228.0M	—	—	—	—	—
Fin CF	12.1M	1.1M	49.6M	172.5M	—	—	—	—	—

Loading 1Y...

PRICE (1Y)+25.8%

SMA 50SMA 200

$41.34

RSI (14)

59.1

52W High

$42.55

From 52W High

1.0%

SCORE BREAKDOWN

Quality

ROIC

6.4%62.5

ROE

10.0%72.3

GP/Assets

20.8%49.3

Op. Margin

5.9%58.3

FCF/Assets

2.0%55.3

Piotroski

550.0

Int. Cover

7.8x58.1

D/E Ratio

1.17x12.0

Current Ratio

1.19x16.2

Value

P/E (TTM)

49.0x21.8

EV/EBITDA

29.6x19.6

P/FCF

75.0x17.7

P/B

4.1x33.3

P/S

1.4x76.6

Div Yield

—N/A

Momentum

52W High %

97%96.2

RS 6M

28%89.1

SMA 50/200

1.16x86.6

EPS Rev 4W

+0.5%81.9

EPS Rev 12W

+1.9%70.1

EPS Improve

+90%70.8

Q Growth

10%50.2

FUNDAMENTALS

Market Cap

$1.4B

P/E (Forward)

25.7x

Gross Margin

19.6%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of PNTG are excluded.

Ticker	Company	Mkt Cap	StockRank	Signal
PNTG	The Pennant Group, Inc.(you)	$1.4B	66	BUY
SGRY	Surgery Partners, Inc.	$2.1B	68	BUY
USPH	U.S. Physical Therapy, Inc.	$1.1B	59	HOLD
INNV	InnovAge Holding Corp.	$1.6B	77	BUY
GMRS	GMR Solutions Inc.	$701M	71	BUY
OPCH	Option Care Health, Inc.	$3.4B	61	HOLD
ACHC	Acadia Healthcare Company, Inc.	$3.2B	73	BUY
ASTH	Astrana Health, Inc.	$2.0B	85	STRONG BUY
HCSG	Healthcare Services Group, Inc.	$1.6B	92	STRONG BUY
ARDT	Ardent Health, Inc.	$1.5B	94	STRONG BUY

Peer medians: ROE -25.6% · P/E 27.6x · Gross margin 50.6%

Price	$41.34
Market Cap	$1.4B
P/E (TTM)	48.99
P/E (Forward)	25.74
Price/Book	4.13
Return on Equity	10.0%
Return on Invested Capital	6.4%
Debt/Equity	1.17x
Gross Margin	19.6%
Operating Margin	5.9%
Revenue Growth	36.0%
Free Cash Flow	$19M